|
Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access?
|
June 9, 2022
|
PC3I Authors Charu Aggarwal |
Journal of Clinical Oncology
|
|
Association of the Affordable Care Act’s Medicaid Expansion With 1-Year Survival Among Patients With Ovarian Cancer
|
June 8, 2022
|
PC3I Authors Anna Jo Smith |
Obstetrics and Gynecology
|
|
Real-World Adherence to Patient-Reported Outcome Monitoring as a Cancer Care Quality Metric
|
June 8, 2022
|
PC3I Authors Samuel Takvorian; Peter Gabriel; Larry Shulman |
JCO Oncology Practice
|
|
Using Informatics to Engage Vulnerable Populations in Research: Lessons Learned from the COVID-19 Pandemic
|
June 8, 2022
|
PC3I Authors George Demiris |
Studies in Health Technology and Informatics
|
|
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice
|
June 7, 2022
|
PC3I Authors Ronac Mamtani; Melina Marmarelis |
Pharmacoepidemiology and Drug Safety
|
|
Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database
|
June 6, 2022
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Guideline discordant care in patients with metastatic germ cell tumors
|
June 6, 2022
|
PC3I Authors Larry Shulman |
Urologic Oncology
|
|
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma
|
June 2, 2022
|
PC3I Authors Ronac Mamtani |
Journal of Cancer Research and Clinical Oncology
|
|
Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis
|
June 2, 2022
|
PC3I Authors Anne Marie McCarthy |
Cancer Medicine
|
|
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion
|
June 1, 2022
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine
|
June 1, 2022
|
PC3I Authors Larry Shulman |
JCO Global Oncology
|
|
Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study
|
June 1, 2022
|
PC3I Authors Katharine Rendle; Jocelyn Wainwright; Hannah Toneff; Surbhi Grover |
BMC Women's Health
|
|
Digital Health Applications in Oncology: An Opportunity to Seize
|
May 31, 2022
|
PC3I Authors Larry Shulman |
Journal of the National Cancer Institute
|
|
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
|
May 31, 2022
|
PC3I Authors Charu Aggarwal |
Journal for Immunotherapy of Cancer
|
|
The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward
|
May 31, 2022
|
PC3I Authors Larry Shulman |
Journal of the National Cancer Institute
|
|
Redressing breast cancer screening disparities during the COVID-19 pandemic: Turning crisis into opportunity
|
May 31, 2022
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
American Journal of Surgery
|
|
Perceptions of and Experiences with Consumer Sleep Technologies That Use Artificial Intelligence
|
May 28, 2022
|
PC3I Authors George Demiris |
Sensors
|
|
Finding the Lowest-Cost Pharmacy for Cancer Supportive Care Medications: Not So Easy
|
May 27, 2022
|
PC3I Authors Ramy Sedhom |
JCO Oncology Practice
|
|
Toward Equitable Access to Tertiary Cancer Care in Rwanda: A Geospatial Analysis
|
May 27, 2022
|
PC3I Authors Larry Shulman |
JCO Global Oncology
|
|
Oncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial
|
May 27, 2022
|
PC3I Authors Larry Shulman |
PLoS One
|
